Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia

Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia

Introduction: We performed cost-effectiveness and cost-utility analyses of the modified International Consortium on Acute Promyelocytic Leukemia protocol in Mexico for the treatment of acute promyelocytic leukemia Acute Promyelocytic Leukemia. Methods: We performed a three-state Markov analysis: sta...

Full description

Bibliographic Details
Main Authors: Sergio Rodríguez-Rodríguez, Lorena Guerrero-Torres, María José Díaz-Huízar, Alan Pomerantz, María del Pilar Ortíz-Vilchis, Roberta Demichelis-Gómez
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Acute promyelocytic leukemia
All-trans retinoic acid
IC-APL
Cost-effectiveness
Cost-utility
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920302844

Internet

http://www.sciencedirect.com/science/article/pii/S2531137920302844

Similar Items